within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AE01_Saquinavir;
model Saquinavir 
   extends Pharmacolibrary.Drugs.ATC.J.J05AE01;

  annotation(Documentation(
    info ="<html><body><p>Saquinavir is a protease inhibitor used as an antiretroviral agent in the treatment of HIV-1 infection. It was one of the first protease inhibitors approved for use but is now less commonly used due to newer agents with improved safety and efficacy. It is used in combination antiretroviral therapy for managing HIV/AIDS.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for HIV-infected adult patients, both male and female, under steady-state conditions receiving oral saquinavir-hardshell capsules 600 mg three times daily.</p><h4>References</h4><ol><li><p>Niemi, M, et al., &amp; Kivistö, KT (2003). Pharmacokinetic interactions with rifampicin : clinical relevance. <i>Clinical pharmacokinetics</i> 42(9) 819–850. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200342090-00003&quot;>10.2165/00003088-200342090-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12882588/&quot;>https://pubmed.ncbi.nlm.nih.gov/12882588</a></p></li><li><p>Buchanan, CM, et al., &amp; Wempe, MF (2008). Pharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-beta-cyclodextrin formulations. <i>Biomacromolecules</i> 9(1) 305–313. DOI:<a href=&quot;https://doi.org/10.1021/bm700827h&quot;>10.1021/bm700827h</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18072746/&quot;>https://pubmed.ncbi.nlm.nih.gov/18072746</a></p></li><li><p>Hu, Z, et al., &amp; Zhou, S (2005). Herb-drug interactions: a literature review. <i>Drugs</i> 65(9) 1239–1282. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200565090-00005&quot;>10.2165/00003495-200565090-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15916450/&quot;>https://pubmed.ncbi.nlm.nih.gov/15916450</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Saquinavir;
